Skip to content
Search

Latest Stories

RPS launches new post approval service for consultant pharmacists

The Royal Pharmaceutical Society (RPS) today launched a new centralised post approval service for NHS consultant pharmacists in England and Wales.

Outlined in the new NHS guidance on consultant pharmacist, the service will ensure consistency of approach and quality assurance for the job.


According to RPS, the service will consider the level of practice expected of the post holder, the proposed impact of the role across the healthcare system, succession planning as well as the arrangements for management, supervision and job planning.

Employers and organisations can submit consultant post approval application through RPS website, which will be reviewed by an expert panel.

RPS is currently recruiting for an expert panel and the deadline for application is January 27.

Keith Ridge, Chief Pharmaceutical Officer for England, and Andrew Evans, Chief Pharmaceutical Officer for Wales, said: “Consultant pharmacist level expertise is critical to ensuring people get the support they need to maximise the benefits and reduce the risks associated with using increasingly complex medicines.”

“A single, national credentialing process for the NHS in England and Wales will set a uniform standard for consultant pharmacist roles and, importantly, stimulate the development of new consultant pharmacist posts according to population health needs.”

RPS will maintain a public-facing directory of approved consultant pharmacist posts. However, current posts need not be re-approved by the new centralised service.

Gail Fleming, RPS Director for Education and Professional Development said: “We believe that the new process to recognise posts is the gold standard and one that should be considered by other professions. Supporting the implementation of the new guidance is a clear role for the professional leadership body and a big step forward in ensuring that posts are developed strategically and at the appropriate level."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less